SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid overnight gains and renewed community speculation, with some citing Roaring Kitty's activity and Michael Burry's old emails as potential catalysts. Community members are weighing whether this is a buying opportunity or just hype, with many anticipating a short squeeze and closely watching upcoming earnings. Some users are drawing comparisons to the 2021 frenzy.

Joe Coin

Joe Coin is experiencing increased volatility, with community members noting signs of bullish momentum and accumulation. Discussions revolve around key price levels and triggers for potential breakouts, with some speculating on a possible shift in market sentiment. The coin's small market cap and meme-driven nature contribute to its rapid price movements.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices test new highs, triggering discussions about a potential breakout. Community members are debating whether the recent price action signals a genuine surge or is subject to manipulation, while also considering the broader implications of silver's role as an industrial metal and a hedge against economic uncertainty. Some traders point to technical formations, anticipating a sustained rally, while others express caution.

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Quantum BioPharma Ltd

Quantum BioPharma ($QNTM) is trending due to increased community interest and discussion around its $700M lawsuit alleging market manipulation, coupled with positive clinical trial news for its MS treatment, Lucid-MS. The community is actively discussing potential short squeezes, overnight price action in the Canadian market, and comparing QNTM to other trending stocks with similar market dynamics. Some investors express confidence in the stock's long-term potential, while others remain skeptical.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU is trending as community members highlight ongoing real-world initiatives, brand recognition, and a growing ecosystem of businesses.  Enthusiasts emphasize the strong community building, active development, and various products being launched under the $KENDU umbrella. Community members suggest that the project's ambition sets it apart in the crypto space.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending due to community excitement around its potential as foundational infrastructure for TradFi, emphasized by its high throughput and compliance-aware design. Investors are actively discussing the token's value proposition in comparison to major platforms like Amazon, Google, and Microsoft, viewing KTA as a targeted bet on the future of financial plumbing. The community also highlights potential partnerships, particularly with Stripe, as a key catalyst.

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Verrica Pharmaceuticals Inc

VRCA is trending due to recent news, including a Zacks Small Cap Research report with a price target of $30 and insider confidence, with a director investing $17.5 million. Community members are discussing a potential short squeeze, while others focus on the company's financing, including a private placement to retire debt and extend its cash runway into mid-2027, while biotech as a sector is seeing increased interest.

This first memecoin ever created completely by AI.

Turbo Toad Token

Turbo Toad Token ($TURBO) is trending as traders discuss its potential for upward movement and a possible breakout, with some eyeing a return to previous highs. Community members are weighing bullish signals against concerns about resistance levels, debating whether to hold for a significant surge or take profits. Discussions also include speculation around new exchange listings and comparisons to other meme coins.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending as Bitcoin experiences volatility, leading to active discussions about potential bottom levels and future price movements. Community members are analyzing technical indicators and options data to gauge market sentiment, while also considering broader economic factors that could influence Bitcoin's trajectory. The conversation includes both bullish and bearish perspectives, with some highlighting large fund investments and others pointing to ETF outflows.

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Bio-Techne Corp

Bio-Techne ($TECH) is trending as the community discusses recent rating updates and price target adjustments from analysts, with some highlighting a potential buying opportunity. News around spatial biology advancements and new partnerships are also sparking interest. Investors are weighing revenue performance and margin stability amid a challenging biotech environment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rockefeller Capital Management L.P. Sells 503,422 Shares of Progyny, Inc. $PGNY

Rockefeller Capital Management L.P. cut its holdings in Progyny, Inc. (NASDAQ:PGNY - Free Report) by 88.9% during the second quarter, according to the company in its most recent Form 13F filing with...

Progyny (NASDAQ:PGNY) Sets New 12-Month High - Here's What Happened

Progyny (NASDAQ:PGNY) Reaches New 12-Month High - What's Next...

Universal Beteiligungs und Servicegesellschaft mbH Has $2.58 Million Holdings in Progyny, Inc. $PGNY

Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 34.7% during the 2nd quarter, according to its most recent disclosure...

Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue?

Pediatrix Medical Group (MD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes"

Progyny (PGNY) possesses solid growth attributes, which could help it handily outperform the market.

Progyny, Inc. $PGNY Shares Sold by CenterBook Partners LP

CenterBook Partners LP cut its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 77.9% in the 2nd quarter, according to the company in its most recent filing with the Securities...

Insider Selling: Progyny (NASDAQ:PGNY) CFO Sells 21,303 Shares of Stock

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) CFO Mark Livingston sold 21,303 shares of the firm's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $25.50...

Bank of New York Mellon Corp Sells 16,655 Shares of Progyny, Inc. $PGNY

Bank of New York Mellon Corp lessened its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 3.3% during the second quarter, according to the company in its most recent 13F filing with...

Progyny (NASDAQ:PGNY) Hits New 12-Month High Following Insider Buying Activity

Progyny (NASDAQ:PGNY) Sets New 12-Month High Following Insider Buying Activity...

Peter Anevski Buys 79,500 Shares of Progyny (NASDAQ:PGNY) Stock

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) CEO Peter Anevski purchased 79,500 shares of the business's stock in a transaction that occurred on Thursday, November 13th. The stock was bought at an...

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

PGNY
Progyny Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGNY News

PGNYProgyny Inc